Alessandro Mattina

Dr. Alessandro Mattina

Diabetes Service, IRCCS ISMETT-UPMC, Palermo, Sicilia, Italy
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2012 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
SBSilvio Buscemi
Silvio Buscemi
GRGiuseppe Rosafio
Giuseppe Rosafio
GAGioacchina Arcoleo
Gioacchina Arcoleo
Alessandro MattinaAlessandro Mattina
Alessandro Mattina
BCBaldassare Canino
Baldassare Canino
GRGiovanbattista Rini
Giovanbattista Rini
Background: Oxidative and inflammatory stresses are involved in the pathogenesis of atherosclerosis. The consumption of fruit and vegetables is associated with improved health and reduced cardiovascular risk. Red oranges have a high content of antioxidant and antiinflammatory substances, but there is a paucity of data concerning their effects on cardiovascular biomarkers in subjects with increased cardiovascular risk.

3 February 2010 in European Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
SBSilvio Buscemi
Silvio Buscemi
SVS Verga
S Verga
JBJ A Batsis
J A Batsis
MDM Donatelli
M Donatelli
MTM R Tranchina
M R Tranchina
GCG Cerasola
G Cerasola

15 July 2010 in Diabetic Medicine
Verified
Journal Article
Closed access
PDF file
SBSilvio Buscemi
Silvio Buscemi
ARA. Re
A. Re
JBJ. A. Batsis
J. A. Batsis
MAM. Arnone
M. Arnone
Alessandro MattinaAlessandro Mattina
Alessandro Mattina
SVS. Verga
S. Verga

1 June 2016 in Journal Of Hypertension
Verified
Journal Article
Closed access
DRDavid Rosenbaum
David Rosenbaum
Alessandro MattinaAlessandro Mattina
Alessandro Mattina
EKEdouard Koch
Edouard Koch
FRFlorence Rossant
Florence Rossant
AGAntonio Gallo
Antonio Gallo
XGXavier Girerd
Xavier Girerd
In humans, adaptive optics camera enables precise large-scale noninvasive retinal microcirculation evaluation to assess ageing, blood pressure and antihypertensive treatments respective roles on retinal arterioles anatomy. We used adaptive optics camera rtx1 (Imagine-Eyes, Orsay, France) to measure wall thickness, internal diameter and to calculate wall-to-lumen ratio (WLR) and wall cross-sectional area of retinal arterioles. This assessment was repeated within a short period in two subgroups of hypertensive individuals without or with a drug-induced blood pressure drop. In 1000 individuals, mean wall thickness, lumen diameter and WLR were 23.2 ± 3.9, 78.0 ± 10.9 and 0.300 ± 0.054 μm, respectively. Blood pressure and age both independently increased WLR by thickening arterial wall. In opposite, hypertension narrowed lumen in younger as compared to older individuals (73.2 ± 9.0 vs. 81.7 ± 10.2 μm; P < 0.001), whereas age exerted no influence on lumen diameter. Short-term blood pressure drop (-29.3 ± 17.3/-14.4 ± 10.0 mmHg) induced a WLR decrease (-6.0 ± 8.0%) because of lumen dilatation (+4.4 ± 5.9%) without wall thickness changes. By contrast, no modifications were observed in individuals with stable blood pressure. In treated and controlled hypertensives under monotherapy WLR normalization was observed because of combined wall decrease and lumen dilatation independently of antihypertensive pharmacological classes. In multivariate analysis, hypertension drug regimen was not an independent predictor of any retinal anatomical indices. Retinal arteriolar remodeling comprised blood pressure and age-driven wall thickening as well as blood pressure-triggered lumen narrowing in younger individuals. Remodeling reversal observed in controlled hypertensives seems to include short-term functional and long-term structural changes.

26 October 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
Guido GembilloGuido Gembillo
Guido Gembillo
LVLuca Visconti
Luca Visconti
MGMaria Ausilia Giusti
Maria Ausilia Giusti
Rossella SiligatoRossella Siligato
Rossella Siligato
AGAlessia Gallo
Alessia Gallo
Alessandro MattinaAlessandro Mattina
Alessandro Mattina
Cardiorenal syndrome (CRS) is a multi-organ disease characterized by the complex interaction between heart and kidney during acute or chronic injury. The pathogenesis of CRS involves metabolic, hemodynamic, neurohormonal, and inflammatory mechanisms, and atherosclerotic degeneration. In the process of better understanding the bi-directional pathophysiological aspects of CRS, the need to find precise and easy-to-use markers has also evolved. Based on the new pathophysiological standpoints and an overall vision of the CRS, the literature on renal, cardiac, metabolic, oxidative, and vascular circulating biomarkers was evaluated. Though the effectiveness of different extensively applied biomarkers remains controversial, evidence for several indicators, particularly when combined, has increased in recent years. From new aspects of classic biomarkers to microRNAs, this review aimed at a 360-degree analysis of the pathways that balance the kidney and the heart physiologies. In this delicate system, different markers and their combination can shed light on the diagnosis, risk, and prognosis of CRS.

18 September 2013 in European Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
SBSilvio Buscemi
Silvio Buscemi
ANA Nicolucci
A Nicolucci
Alessandro MattinaAlessandro Mattina
Alessandro Mattina
GRG Rosafio
G Rosafio
FMF M Massenti
F M Massenti
GRG B Rini
G B Rini